The High Court has ruled that NHS England is able to fund HIV Pre-Exposure Prophylaxis (PrEP) through its specialised commissioning process. Denton and Reddish MP Andrew Gwynne, along with other Members of Parliament, have been placing pressure on NHS England to commission the drug for several months.
Gwynne, alongside other Parliamentarians, expressed approval of the initial outcome of the court case, but have written to NHS England CEO, Simon Stevens, to call on him to ensure adequate care is given to PROUD participants high risk MSM patients as a matter of urgency.
They have called on NHS England to speed up its implementation plan to avoid as many new diagnoses as possible.
Andrew Gwynne MP said:
“I am pleased with the court ruling, however I am deeply concerned about the timetable set for its implementation.
“Given that HIV rate continue to rise in the UK, it is important that PrEP becomes available as soon as possible. Prevention is far better than post-diagnosis treatment, not only for the wellbeing of patients, but as a long term cost for NHS England.
“Any new HIV diagnosis between now and the full implementation of PrEP is an avoidable calamity for both the patient and NHS England. Patients need urgent and reliable access to PrEP. No high risk individuals should be denied this ground breaking drug.”